Metabolon, Geisinger Team on Prediabetes Study | GenomeWeb

NEW YORK (GenomeWeb) – Metabolon announced that it is partnering with Geisinger Medical Center in Danville, Pa., on a pilot study to evaluate Metabolon's Quantose IR test in monitoring glycemic control in people with prediabetes.

The study will monitor prediabetic subjects over a 12-week period using the Quantose IR test and evaluate hemoglobin A1c and fasting plasma glucose results. Participants in the study will receive metformin treatment and also will be on a regiment of diet and exercise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.